中华老年医学杂志
中華老年醫學雜誌
중화노년의학잡지
Chinese Journal of Geriatrics
2013年
10期
1062-1065
,共4页
刘振千%冯华松%姜义%张春阳
劉振韆%馮華鬆%薑義%張春暘
류진천%풍화송%강의%장춘양
肺炎%呼吸功能不全%连续气道正压通气
肺炎%呼吸功能不全%連續氣道正壓通氣
폐염%호흡공능불전%련속기도정압통기
Pneumonia%Respiratory insufficiency%Continuous positive airway pressure
目的 评价无创正压通气(NPPV)对老年社区获得性肺炎呼吸衰竭的疗效. 方法 将321例无心肺复苏、呼吸停止、严重血流动力学不稳定等需紧急气管插管,平均年龄(75.6±12.2)岁伴呼吸衰竭的社区获得性肺炎患者,随机分配给予NPPV(162例)或标准氧疗(159例)作为呼吸衰竭救治方法,比较其插管率、呼吸衰竭控制率及病死率,筛选影响因素. 结果 全部患者中,90%为Ⅰ型呼吸衰竭,NPPV组治疗失败插管率低于标准氧疗组(46.9%比64.2%,x2=9.652,P<0.01),但两组呼吸衰竭控制率无差别(77.9%比72.3%,x2=1.274,P>0.05),30 d病死率及90 d累积生存率亦无差别.NPPV治疗失败者病死率高于成功者(48.7%比11.6%,x2=26.900,P<0.01).NPPV治疗失败、简易急性生理评分和年龄高、多肺叶病变是死亡的独立危险因素. 结论 NPPV 可降低老年社区获得性肺炎Ⅰ型呼吸衰竭的插管率,但总体疗效并不突出,应用时需警惕延误插管.
目的 評價無創正壓通氣(NPPV)對老年社區穫得性肺炎呼吸衰竭的療效. 方法 將321例無心肺複囌、呼吸停止、嚴重血流動力學不穩定等需緊急氣管插管,平均年齡(75.6±12.2)歲伴呼吸衰竭的社區穫得性肺炎患者,隨機分配給予NPPV(162例)或標準氧療(159例)作為呼吸衰竭救治方法,比較其插管率、呼吸衰竭控製率及病死率,篩選影響因素. 結果 全部患者中,90%為Ⅰ型呼吸衰竭,NPPV組治療失敗插管率低于標準氧療組(46.9%比64.2%,x2=9.652,P<0.01),但兩組呼吸衰竭控製率無差彆(77.9%比72.3%,x2=1.274,P>0.05),30 d病死率及90 d纍積生存率亦無差彆.NPPV治療失敗者病死率高于成功者(48.7%比11.6%,x2=26.900,P<0.01).NPPV治療失敗、簡易急性生理評分和年齡高、多肺葉病變是死亡的獨立危險因素. 結論 NPPV 可降低老年社區穫得性肺炎Ⅰ型呼吸衰竭的插管率,但總體療效併不突齣,應用時需警惕延誤插管.
목적 평개무창정압통기(NPPV)대노년사구획득성폐염호흡쇠갈적료효. 방법 장321례무심폐복소、호흡정지、엄중혈류동역학불은정등수긴급기관삽관,평균년령(75.6±12.2)세반호흡쇠갈적사구획득성폐염환자,수궤분배급여NPPV(162례)혹표준양료(159례)작위호흡쇠갈구치방법,비교기삽관솔、호흡쇠갈공제솔급병사솔,사선영향인소. 결과 전부환자중,90%위Ⅰ형호흡쇠갈,NPPV조치료실패삽관솔저우표준양료조(46.9%비64.2%,x2=9.652,P<0.01),단량조호흡쇠갈공제솔무차별(77.9%비72.3%,x2=1.274,P>0.05),30 d병사솔급90 d루적생존솔역무차별.NPPV치료실패자병사솔고우성공자(48.7%비11.6%,x2=26.900,P<0.01).NPPV치료실패、간역급성생리평분화년령고、다폐협병변시사망적독립위험인소. 결론 NPPV 가강저노년사구획득성폐염Ⅰ형호흡쇠갈적삽관솔,단총체료효병불돌출,응용시수경척연오삽관.
Objective To evaluate the efficacy of noninvasive positive-pressure ventilation (NPPV) on acute respiratory failure (ARF) in elderly patients with severe community-acquired pneumonia (CAP).Methods 321 CAP patients with ARF aged over 65 years [(75.6±12.2) years old in averag] were randomly treated with NPPV (n=162) and the standard oxygen therapy (n=159).Intubation rate,ARF control rate and total mortality were compared between the two groups,and the risk factors were analyzed.Results 90% of 321 patients presented with hypoxemic respiratory failure.Compared with standard therapy group,the intubation rate was lower in NPPV group (46.9% vs.64.2%,x2=9.652,P<0.01).However,there were no differences in ARF control rate(77.9% vs.72.3%,x2 =1.274,P>0.05),overall 30-day mortality and 90-day survival between the two groups.The overall mortality in NPPV group was higher in treatment failure cases than in treatment success cases (48.7% vs.11.6%,x2=26.900,P<0.01).The independent risk factors for death were treatment failure in NPPV,higher simplified acute physiology score assessment,old age and mutilobar infiltrate.Conclusions NPPV can decrease the intubation rate in CAP patients with acute hypoxemic respiratory failure,but the overall efficacy is not significant.Delayed intubation should be avoided when NPPV is to be applicated.